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Abstract:
Background:
Whilst the prevalence of autism spectrum disorders in adults within the community setting is well-established, less is known about
the prevalence among adults based within a psychiatric inpatient setting.
Objective:
To conduct a systematic literature review pertaining to the prevalence of autism spectrum disorders among the adult psychiatric
inpatient population.
Method:
Eligibility criteria included: (a) investigation of the prevalence of autism spectrum disorders (b) adult psychiatric inpatient study
population (c) published in English language. Electronic databases accessed included PubMed, Medline, CINAHL, PsycINFO and
EMBASE. Additionally, the ancestry method was utilised for the references of eligible papers, as well as grey literature searches and
consultation with experts in the field.
Results:
From the  search,  4  studies  were  identified  which  satisfied  the  inclusion  criteria,  conducted  in  a  variety  of  inpatient  psychiatric
settings, including secure forensic and intellectual disability units and a state psychiatric hospital. There were significant differences
in methodological approaches, including the screening tests, diagnostic instruments and diagnostic criteria utilised. Autism spectrum
disorder prevalence estimates varied considerably, from 2.4-9.9%.
Conclusion:
From  the  limited  research  data  currently  available,  it  appears  that  the  prevalence  of  autism  spectrum  disorders  is  increased  in
inpatient psychiatric settings relative to the general population. There is a need for further high quality research in this patient group,
to add to this limited evidence base, as well as in developing effective strategies to identify patients with a high likelihood of autism
spectrum disorders within this setting.
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1. INTRODUCTION
Autism Spectrum Disorders (ASD) describe a range of neurodevelopmental disorders characterised by difficulties in
social interaction and communication, as well as restricted, stereotyped and repetitive behaviours [1]. ASD subtypes
include autism, Asperger’s Syndrome (AS) and Pervasive Developmental Disorder Not Otherwise Specified (PDD-
NOS); a further two PDD’s exist (Rett’s syndrome and childhood disintegrative disorder), though these are qualitatively
distinct from the aforementioned subtypes, and are thus not considered further in this review [2]. Though originating in
childhood, the debilitating effects of ASD persist into later life, leading to many individuals requiring high levels of
support throughout their adult life [3]. Indeed, whilst most research has historically focussed on ASD in children, in
recent years there has been an increasing focus on the clinical needs of adult patients [4]. Despite this, service provision
for adults with ASD is still in its relative infancy [5]. An important component of this is ready access to diagnostic
services for adults with suspected ASD, as diagnosis is essential in both understanding their needs and planning their
subsequent care [6].
Community-based prevalence rates for autism in the general population show considerable variation across studies,
though recent systematic reviews and large-scale epidemiological research estimate rates of between 0.7-1.1% [7, 8].
Additionally, the prevalence of autism is significantly higher in people with moderate to profound intellectual disability
(ID);  Brugha  et  al.  [8]  found  a  prevalence  of  39.3%  (95%  confidence  interval  31.0-48.4)  for  this  patient  group,
compared to 1.0% (95% confidence interval 0.4-2.2) for those with mild ID. For these reasons, ASD represents a major
global public health issue, responsible for over 111 Disability Adjusted Life Years (DALY’s) per 100,000 persons [7].
However,  while  there  has  been  a  focus  on  the  prevalence  of  ASD  in  the  community,  its  prevalence  within  an
inpatient  psychiatric  setting  is  less  well  established.  Mandell  et  al.  [9]  (2012)  cited  several  reasons  to  support  the
suggestion that ASD may be overrepresented and underdiagnosed among adults within such a setting, including a lack
of  training  among  adult  psychiatrists  in  conditions  originating  in  childhood.  Additionally,  presence  of  comorbid
psychiatric disorders that are more common in people with ASD could potentially complicate the diagnostic picture [9,
10], including depression [11, 12], bipolar disorder [13], anxiety disorders [14], schizophrenia [13, 15], attention deficit
hyperactivity disorder [11, 14], alcohol and substance abuse [13], as well as ID [16, 17]. Such conditions could lead to
instances of failure to identify ASD where present, as well as misattribution of ASD symptoms to other forms of mental
disorder, such as schizophrenia [9, 15]. Finally, the diagnostic criteria for ASD have broadened in recent decades, in
contrast to the narrowing of those for schizophrenia [9, 18 - 20].
Understanding  the  prevalence  of  ASD  within  an  inpatient  psychiatric  setting  has  significant  implications  for
resource  allocation  by  healthcare  providers,  as  this  patient  group  could  potentially  represent  a  target  for  case
identification.  Identifying  individuals  with  ASD  will  ensure  that  the  clinical  needs  of  such  individuals  are  better
understood, and taken into account in any subsequent treatment approach [15]. This could potentially lead to improved
therapeutic outcomes in both the shorter (e.g reduced length of hospital stay) and longer terms (e.g reduced likelihood
of readmission).
The purpose of this systematic review was to evaluate the current evidence pertaining to the prevalence of ASD in
adults within an inpatient psychiatric setting. This is the first systematic review on this topic.
2. MATERIALS AND METHODS
2.1. Systematic Search Strategy
The  PubMed,  MedLine,  CINAHL,  PsycINFO  and  EMBASE  databases  were  searched  from  their  respective
inceptions  to  10th  December  2017.  Titles  and  abstracts  were  searched  for  the  following  terms:  (((autism  spectrum
disorders  OR  autis*  OR  Asperger*  OR  PDD  OR  PDDs  OR  PDD-NOS  OR  ASD  OR  ASDs  OR  pervasive
development* disorder* OR Kanner*))) AND (((prevalen* OR screen* OR rate*))) AND (((adult))). Please note that
autis* was used as a search term to cover titles and abstracts containing either ‘autism’ or ‘autistic’; prevalen* was used
as a search term to cover titles and abstracts containing either ‘prevalence’ or ‘prevalent’. All titles and abstracts of
articles that remained following removal of duplicates were screened against the inclusion criteria by two investigators
(ST + VC). If they were considered to potentially satisfy inclusion criteria, full texts were accessed. In instances where
there was uncertainty between ST and VC regarding the eligibility of an article, the final decision was made by RK. The
ancestry  method  was  utilised  to  identify  additional  studies  within  the  references  of  eligible  papers.  Grey  literature
searches included Google Scholar and manual searches. Experts in the field were consulted to identify any additional
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published  or  unpublished  data;  for  all  articles  identified  via  expert  consultation,  the  full  texts  of  the  articles  were
assessed. Two separate searches were conducted by the local research design and library services, to find studies not
identified by the above methods. The details of the search were registered on the PROSPERO database (Registration
No. CRD42017084616).
2.2. Study Selection
Studies were included provided they satisfied all of the following criteria: (a) investigation of the prevalence of
autism spectrum disorders within a psychiatric inpatient population (b) adult patients (≥ 16 years of age) (c) published
in  English  language.  Please  note  that  a  basic  requirement  for  ‘investigation  of  the  prevalence  of  autism  spectrum
disorders’ was that all participants within the study population were subjected to some form of autism-specific testing.
Several studies were identified which simply reported the proportions of inpatients whom were identified as having
autism through routine clinical  practice;  for  the purposes of  this  review, these were not  considered true prevalence
studies  and  were  excluded  accordingly.  Such  studies  would  likely  underestimate  prevalence,  as  the  diagnostic
possibility of autism is not being proactively assessed using relevant assessment tools in all individuals within the study
population.
2.3. Data Extraction
For  each  article,  data  was  extracted  pertaining  to  the  year  and  location  of  the  study,  as  well  as  the  number  of
individuals enrolled, screened (where applicable) and undergoing full diagnostic assessment. The methods employed for
such assessments were also obtained, as well as the ASD diagnostic criteria used. Where available, information was
also  extracted  regarding  the  individuals  included  as  well  as  excluded  from the  study,  as  this  would  impact  on  the
generalisability  of  any  resultant  prevalence  estimate.  The  proportion  of  male  patients  was  also  documented,  as  to
determine whether the study proportion disproportionately represented one gender over another.
2.4. Data Synthesis
The prevalence results obtained were considered both with regard to overall findings for ASD prevalence across
available studies, as well as specifically within ID, non-ID and forensic subgroups.
2.5. Quality Assessment
All articles that qualified for inclusion were stored by one investigator (ST) according to the 22-item STROBE
checklist  of  cross-sectional  studies  [21],  as  all  studies  were  of  this  type.  No  studies  qualifying  for  inclusion  were
excluded based upon their STROBE score.
3. RESULTS
3.1. Study Characteristics
Database searches were conducted on 10th December 2017. The database search yielded a total of n=7463 articles,
including  n=2885  articles  in  PubMed,  n=1199  articles  in  MedLine,  n=296  articles  in  CINAHL,  n=1045  articles  in
PsycINFO  and  n=2038  articles  in  EMBASE.  A  total  of  n=80  additional  records  were  identified  through  other
techniques  (ancestry  method,  grey  literature  searches  and  expert  consultation).  Following  removal  of  duplicates,
n=4237 articles remained for screening. Fig. (1) illustrates a PRISMA flow chart summary of the systematic search.
Upon  abstract  screening,  a  further  4126  articles  were  excluded  for  a  variety  of  reasons,  including  focusing  on
research  topics  unrelated  to  Autism Spectrum Disorder  (such  as  Atrial  Septal  Defect),  failing  to  satisfy  the  search
criteria (e.g studies on child populations, not measuring prevalence of Autism etc.), or not being published in English
language. Thus, full texts of 111 articles were assessed, of which 4 qualified for inclusion. Of the included papers, 3
were identified on the initial database search, and 1 via the ancestry method. Grey literature searches and liaison with
experts failed to identify any additional studies satisfying inclusion criteria.
3.2. Findings of Included Studies
Table 1 summarises the details of all four included studies. Publication dates for such studies ranged from 1982 to
2012, and all were conducted in England or North America. The characteristics of the study samples varied markedly,
including both state [9] and secure psychiatric hospitals [22, 23], as well as long-stay treatment facilities for individuals
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with ID [24]. Limited data were available on the mean age for many included studies (though all were conducted on
adult  populations),  with  mean age  ranging  from 42 to  52  years.  For  all  included  studies,  the  majority  of  the  study
population comprised of males, though this varied considerably from 61-100%. All included studies were found via the
database searching process, with the exception of Hare et al. [23], identified through the ancestry method. No additional
eligible articles were identified through either grey literature searches or consultation with experts in the field.
Fig. (1). PRISMA flow diagram of systematic search [25].
Table 1. Summary of included studies.
Author,
Year,
Location,
Reference
Total N
Enrolled
in Study
N
Screened
N
Indicated
for
Diagnostic
Assessment
N
Subjected
to
Diagnostic
Assessment
Details of
Excluded
Individuals
Male %
Mean Age
in Years
Description
of Inpatient
Setting
Description
of Study
Population
Method of
Screening
Method of
Autism
Diagnosis
Diagnostic
Criteria
Used
Prevalence
Estimate
STROBE
Score
Hare et al.
(1999),
England,
[23]
1305 1305 240 215
Patients on
trial leave to
other
placements
were excluded.
Also, some
were excluded
from initial
screening for
administrative
reasons of no
clinical
significance.
96% of the
special
hospital
population
was screened.
86%
(185/215)
of those
subjected
to
diagnostic
assessment.
Data
pertaining
to the male
% of the
1305
individuals
originally
screened is
not
available.
41.8 (Age
range
20-77
years)
Three secure
psychiatric
hospitals
All adults.
Mixture of
non-ID and
ID patient,
though
details
regarding
the relative
proportions
of each are
not
provided
within the
article.
Autism
Spectrum
Disorder in
Adults
Screening
Questionnaire
(ASDASQ)1
[26].
Handicaps,
Behaviours
and Skills
(HBS)
schedule
[27] and
case note
analysis.
ICD-10 [1]
2.4%
(31/1305),
increased
to 4.8%
(62/1305)
when
equivocal
cases are
taken into
account.
15/22
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Full-text articles assessed for 
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with reasons  
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Studies included in 
qualitative synthesis  
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quantitative synthesis (meta-
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Author,
Year,
Location,
Reference
Total N
Enrolled
in Study
N
Screened
N
Indicated
for
Diagnostic
Assessment
N
Subjected
to
Diagnostic
Assessment
Details of
Excluded
Individuals
Male %
Mean Age
in Years
Description
of Inpatient
Setting
Description
of Study
Population
Method of
Screening
Method of
Autism
Diagnosis
Diagnostic
Criteria
Used
Prevalence
Estimate
STROBE
Score
Mandell
et al.
(2012),
USA, [9]
141
141
(though all
patients
were
subjected
to
diagnostic
assessment
irrespective
of
screening
score)
141 141
There were
348 residents
within the
hospital, so
only 41% were
screened
(141/308).
Researchers
attempted to
obtain consent
from all
residents; 89%
of refusal were
passive (i.e.
patient unable
to give
consent).
Thus, non-
capacitous
individuals
were excluded.
75%
(106/141)
52
State
psychiatric
hospital
Civilly
committed
patient.
32.6%
(46/141)
patients had
ID. Age
range not
given.
Social
Responsiveness
Scale (SRS)
[28].
Four step
process: 1-
Historical
charts and
electronic
records
reviewed; 2
–
Diagnostic
Interview
for Genetics
Studies
(DIGS) [29]
conducted
for each
patient; 3 –
Autism
Diagnostic
Interview –
Revised
(ADI-R)
[30]
completed
by research
reliable
clinicians; 4
– case
conference
review by
two
independent
teams
DSM-IV2
[20]
Overall:
9.9%
(14/141).
ID
subgroup:
19.6%
(9/46).
Non-ID
subgroup:
5.3%
(5/95).
16/22
Scragg
and Shah
(1994),
England,
[22]
392 392 17
17, though
6 refused to
be meet the
investigator
Female patient
excluded, on
basis that
Asperger’s
Syndrome is
reporter to be
much more
common in
males.
100%
(392/392)
No data on
age of
study
population,
though the
study
population
were
adults.
Secure
psychiatric
hospital
(Broadmoor,
England)
Adult
males.
Unclear
whether any
patients in
the study
population
had ID
(details on
IQ are only
given for 9
patients
whom met
criteria for
AS, none of
whom had
an IQ
consistent
with ID).
Examination of
case notes
Two stages
(after initial
screening
stage): 1 –
Screening
Schedule
for Autistic
Behaviour
(Part of the
HBS
interview
schedule)
[27]; 2 –
Interview
by the
investigator.
Gillberg
and
Gillberg
(1989)
[31]
criteria
1.5%
(6/392)
(95% CI –
0.6 to
3.3%),
increased
to 2.3%
with the
addition of
equivocal
cases
(However,
this
estimate
was for
Asperger’s
syndrome
only, rather
than all
forms of
ASD).
12/22
Shah et al.
(1982),
England,
[24]
761 n/a 761 761
Exclusion of
129 patients,
due to being
non-mobile –
‘their inability
to walk
unaided
limited the
possibility of
their showing
the behaviour
pattern
characteristic
of classic
Kanner’s
syndrome.’
61%
(468/761)
No data
for mean
age
available.
Youngest
patients
were 16
years of
age.
Long stay
ID hospital3
The entire
study
population
had ID.
n/a
Disability
Assessment
Schedule
[32]
Details not
provided
within the
article.
4% (27 to
34/761).
The precise
number of
participants
being
diagnosed
with ASD
is not
provided
within the
article,
though
they report
a
prevalence
of 4% from
a study
population
of 761.
12/22
1  Not  referred  to  as  the  ASDASQ within  the  article  itself,  as  the  tool  was  (at  the  time  of  the  Hare  et  al  article  being  published)  an  unnamed,
unpublished screening tool (which was later named the ASDASQ).
2 Confirmed via correspondence with Dr David Mandell.
3 Referred to as a ‘mental handicap hospital’ within the source article.
All but one of the included studies estimated the prevalence of ASD in general, though the methods of diagnosis
(Table ) contd.....
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varied  considerably,  from  review  of  existing  case  notes,  to  using  more  standardised  tools,  such  as  the  Disability
Assessment  Schedule  (DAS)  [32],  Handicaps,  Behaviours  and  Skills  Schedule  (HBS)  [27],  and  the  Diagnostic
Interview for Genetics Studies (DIGS) [29] and Autism Diagnostic Inventory-Revised (ADI-R) [30]. In contrast, Scragg
and Shah [22] estimated the prevalence of AS only, rather than all subtypes of ASD.
Prevalence estimates for ASD ranged from 4 to 9.9%, with Scragg and Shah [22] estimating a prevalence of 1.5%
(or 2.3% when equivocal cases are included) for AS only.
3.3. Subgroup Analyses
Shah et al.  [24], the only eligible study where the entire study population had ID, provided an ASD prevalence
estimate of 4%. Mandell et al. [9] provided an estimate of 19.6% from the subgroup of patients in their study whom had
ID.
Two  studies  involved  a  mixture  of  ID  and  non-ID  individuals.  Mandell  et  al.  [9]  estimated  an  overall  ASD
prevalence of 9.9% whereas Hare et al. [23] estimated 2.4%, increased to 4.8% when equivocal cases were taken into
account.
Though none of the studies were conducted on non-ID patients only, Mandell et al. [9] provided prevalence data
pertaining to the non-ID subgroup of their study population, which yielded a prevalence estimate of 5.3%.
It is important to note that Scragg and Shah [22] do not discuss the ID status of their study population in general,
only providing details that none of the individuals diagnosed with AS had ID. The aforementioned studies conducted by
Hare et al. [23] and Scragg and Shah [22] were both based in forensic settings.
3.4. Qualitative Summary of Relevant Excluded Studies
A brief report by Ferriter et al. [33] was excluded as it represented a summary of the same data covered in the more
comprehensive eligible article by Hare et al. [23], with additional evaluation of the interrater reliability of the ASDASQ
screening tool [26].
A study conducted by Turygin et al. [34] was excluded due to the study population not being subjected to some
form of autism-specific testing, and rather the prevalence estimate of 9.9% (for a population of patients with ID within a
residential treatment facility) being based on case note review and routine clinical assessment alone. There were several
other studies excluded for this reason, such as Esan et al. [35], Gustafsson [36], and Lyall and Kelly [37], among others,
further detailed in the supportive/supplementary material.
An  article  by  Heinrich  et  al.  [38]  was  not  included  due  to  the  study  population  excluding  patients  whom  had
previously  been  assessed  for  ASD,  as  well  as  the  patients  representing  a  mix  of  inpatients  and  community-based
individuals. Their study involved diagnostic assessment of 381 adults with ID (220 male) according to ICD-10 criteria.
Diagnostic  decisions  were  made  as  part  of  a  multidisciplinary  case  conference  involving  review  of  all  available
diagnostic information obtained via standardised ASD tools, including the ADI-R [30], Autism Checklist (ACL) [39],
Autism  Diagnostic  Observation  Schedule  (ADOS)  [40],  scale  of  Pervasive  Developmental  Disorder  in  Mentally
Retarded Persons (PDD-MRS) [41] and Music-based Autism Diagnostics (MUSAD) [42]. A total of 92 patients (24.1%
of the study population) were subsequently diagnosed with ASD.
The most frequent rationales for rejection of the remaining excluded articles for which full text assessments were
undertaken  included  the  study  population  being  based  in  the  community  setting,  the  article  reporting  purely  the
proportion of autistic patients identified through routine clinical practice, the article representing a review rather than
primary research, and the study population being comprised of people with strongly suspected or previously diagnosed
autism. For further details pertaining to excluded studies, as well as the rationale for exclusion of all studies undergoing
assessment of their full texts, please refer to the supportive/supplementary material.
4. DISCUSSION
In this systematic review we aimed to assess the current evidence relating to the prevalence of ASD among adults
within inpatient psychiatric settings. There was a relative dearth of eligible studies, supporting the assertion that there is
a need for further high quality research in order to provide more definitive evidence regarding the prevalence of ASD in
inpatient psychiatric settings.
From this pool of eligible studies, we found wide ranging prevalence estimates, though there appears to be a general
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trend suggesting ASD is more prevalent in inpatient psychiatric settings relative to community populations. The reasons
for such variance in estimates are likely manifold, as there is significant heterogeneity among the eligible studies, in
terms of the characteristics of the patient populations studied, the study design, as well as the assessment tools and
diagnostic criteria used.
With  respect  to  study populations,  it  is  essential  that  in  studies  involving a  mixture  of  ID and non-ID patients,
separate prevalence estimates are made, given the sizeable disparity in ASD prevalence estimates between this groups
in community-based prevalence studies [7, 8, 4, 3]. As a result, the meaningfulness of prevalence estimate for a mixed
ID/non-ID study populations is limited, unless separate data for both groups is also reported. Ideally, patients with ID
should be further sub grouped according to severity of ID, as risk of ASD increases with increasing severity of ID [8].
There was limited evidence among eligible studies pertaining to inpatient prevalence among non-ID adult patients;
however, the only eligible study by Mandell et al. [9] yielded a prevalence of 5.6%, much higher than widely accepted
community prevalence estimates for this group [7]. Clearly more research in non-ID inpatient populations is required to
discern whether this result is valid and generalizable.
Additionally, there were no eligible studies focussed on ASD prevalence among groups of patients with discrete
mental disorders, such as schizophrenia. This is an important area for future research, as it would shed light on both the
extent  of  ASD  comorbidity  with  specific  conditions,  as  well  as  further  explore  diagnostic  overshadowing  in  this
context.
The  data  on  inpatients  with  ID  showed  significant  variability  in  terms  of  prevalence  estimates,  ranging  from
4-19.6%. Given the wide-ranging estimates from studies conducted over a considerable time period, it is impossible to
assert  with  confidence  whether  this  represents  a  significantly  different  prevalence  than  in  patients  with  ID  in  the
community setting [43].
All eligible studies were focussed on predominantly male study populations. Of the two studies reporting data on
gender differences, one described non-statistically significant differences (p> 0.05) in ASD prevalence between males
and females [9] and the other [23] reported a higher prevalence rate among males of those whom were subjected to
diagnostic assessment, though did not comment on whether this was statistically significant. Further work needs to be
done to determine whether there is a difference in ASD prevalence in the psychiatric inpatient setting, as well as more
generally. There has been a long-held belief that ASD is more prevalent in males than females, particularly in those
without ID [44], though it is being increasingly questioned whether this represents a ‘true difference’, or is attributable
to  other  factors,  such  as  ASD screening  and  diagnostic  tests  being  insufficiently  sensitive  for  females  [45],  and/or
females possibly having a greater ability to mask their symptoms (so-called ‘camouflaging’) [46].
Based  on  the  findings  from the  eligible  studies,  including  those  conducted  in  a  forensic  setting  [22,  23],  there
appears to be a general trend suggestive of an increased prevalence of ASD within inpatient psychiatric settings. This
data  from  forensic  units  could  however  be  confounded  by  other  factors,  such  as  a  lack  of  data  on  the  number  of
individuals with ID in both studies. While it is conceivable that the clinical features present in ASD, such as abnormal
social interaction and communication, could predispose someone to offending, there is limited evidence to support the
notion  that  people  with  ASD are  at  any  greater  risk  of  committing  crimes  than  the  non-ASD population,  with  the
possible exceptions of  arson and sexual  abuse [47].  Furthermore,  even if  there were an increased risk of  offending
behaviours in those with ASD, this would not necessarily manifest itself as an increased prevalence within a forensic
psychiatric  inpatient  setting,  as  many  individuals  with  ASD  may  remain  undiagnosed,  avoid  conviction  for  their
offences or be dealt with via the criminal justice system route.
Several studies employed a multiple-stage study design, involving use of a screening tool to determine those whom
progress to more comprehensive diagnostic assessment. Such an approach has similarly been used in community-based
ASD prevalence studies in both child [48, 49] and adult populations [50]. This is logistically sensible, as many of the
ASD diagnostic assessment tools are informant dependent and resource intensive, requiring a considerable amount of
time  and  specialist  input  [50].  For  these  reasons,  a  multiple-stage  approach  enables  coverage  of  a  larger  patient
population  per  unit  of  resources  [51].  Of  course,  the  value  of  such  an  approach  is  contingent  on  the  validity  and
reliability of both the constituent screening and diagnostic tests used.
Diagnostic criteria can have a profound effect on the resultant prevalence estimate; as a community population-
based study by Cooper et al. [43] demonstrated, where ASD prevalence among the same group of 1,023 individuals
with  ID  varied  from  2.0-4.4%  depending  on  the  diagnostic  criteria  used,  and  yielded  a  value  of  7.5%  for  clinical
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diagnosis by a specialist, considered the gold standard. Also, the eligible studies were published across a period of 30
years  and  over  that  time  the  diagnostic  criteria  and  overall  concept  of  ASD  as  a  clinical  entity  have  broadened
considerably [9, 20 - 22]
In conclusion, there is a clear need for robustly conducted epidemiological research pertaining to the prevalence of
ASD among adults in psychiatric inpatient settings, as the current evidence base is lacking. Such research needs to
carefully consider the assessment tools and diagnostic criteria used, as well as a study design supporting coverage of a
large patient group. Additionally, the characteristics of the study population need to be appropriately detailed, with
prevalence estimates for ID and non-ID groups and both genders as a bare minimum requirement. Adult psychiatric
inpatient populations could indeed potentially provide a target for identifying those with ASD, though it is first essential
to  first  establish  whether  ASD  is  truly  significantly  more  prevalent  in  people  within  this  group  relative  to  the
community  setting.
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